Skip to main content
Caplight Logo









CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd.

Public
IsraelHealthcarehttps://collplant.com/

CollPlant Biotechnologies Ltd. is now publicly traded

The data on this page reflects CollPlant Biotechnologies Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jul 6, 2026

Total Funding Raised

$10.4M

Company Overview

CollPlant Biotechnologies Ltd. operates in Healthcare and is based in Israel. It has raised $10.4M.

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company that develops products based on its proprietary recombinant human collagen (rhCollagen) for 3D bioprinting of tissues and organs, medical aesthetics, and advanced wound care.

Sector

Healthcare

AI Layer

Non-AI

CollPlant Biotechnologies Ltd. Comparables

Compare CollPlant Biotechnologies Ltd. with similar companies based on industry and business-model similarity.

CollPlant Biotechnologies Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tempo Therapeutics, Inc.
74%
Spiber Technologies AB
66%
ST1 Co., Ltd.
58%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CollPlant Biotechnologies Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementJul 6, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Eran Rotem

Deputy CEO Chief Financial Officer

Executive Team

Oded Shoseyov

Chief Scientific Officer at CollPlant, Chief Scientific Officer

Executive Team

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • invests_intoSep 3, 2026

    At closing, CollPlant Biotechnologies Ltd., among others, invested $5M in LightSolver Ltd. and issued upfront ordinary shares and pre-funded warrants to support its commercialization, strategic partnerships, and long-term technology roadmap.

  • acquiresAug 31, 2026

    Collplant Limited acquired LightSolver Ltd. for $5M on Aug 31st '26.

Book a demo to see all news

For institutional investors. Book with your work email.

CollPlant Biotechnologies Ltd. Filings

Explore SEC and related filing metadata, where available.

CollPlant Biotechnologies Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

HeadquartersIsrael
Employee Range56
Year Founded2004
Last FundingJul 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?